Yiding Wang
About Yiding Wang
Yiding Wang is the Market Access Strategic Alliance Director for Immuno-Oncology at Bristol-Myers Squibb, based in New York, United States, with extensive experience in market access strategies within the pharmaceutical industry.
Current Title and Company
Yiding Wang holds the position of Market Access Strategic Alliance Director, Immuno-Oncology at Bristol-Myers Squibb. He is currently based in New York, New York, United States.
Previous Work Experience
Yiding Wang has had prior work experience in the field of immuno-oncology, contributing to his extensive knowledge and expertise in market access strategies within the pharmaceutical industry. Specific details about his previous positions were not provided.
Education and Academic Background
Yiding Wang completed his Bachelor of Science degree from Fudan University. He attended the university from 2001 to 2005, earning a comprehensive education that laid the foundation for his career in immuno-oncology and pharmaceutical market access.
Experience in Immuno-Oncology
Yiding Wang has been working in the field of immuno-oncology since March 2016. His role includes developing and implementing market access strategies to ensure the availability and affordability of immuno-oncology treatments.
Global Work Base
While Yiding Wang holds a position in New York, United States, he is based in Shanghai, China. This global work base indicates his capability in managing and overseeing international market access initiatives.